Skip to content
CompanySight
Company No. 07796206 · Incorporated 4 Oct 2011

Pharmareview Limited

Registered name: PHARMAREVIEW LIMITED

Part of Iqvia Holdings Inc. group

Pharmareview Limited made £6m revenue and £47.8m profit in the year to 31 Dec 2025.

Pharmareview Limited’s revenue fell 43% to £6m in the year to 31 Dec 2025, with £47.8m profit and 28 employees. The company is classified under “other professional, scientific and technical activities” and is based in Reading; we hold 4 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 74909Other professional, scientific and technical activities n.e.c.
Status
Active
Location
Reading, South East
Age
15 yrs · since 2011
Type
Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Capital-light
Revenue
£6m
Growth ▼43%
Profit
£47.8m
Growth ▲816.6%
Profit margin
796.8%
Gross 100%
Employees
28
Change ▼61.6%
Profit / employee
£1.7m
Revenue/employee £214k
Profitable streak
4yrs
Consecutive profitable years in our data

Unusual figures. Profit is higher than revenue in this filing. That usually means investment income, dividends from subsidiaries or one-off gains — or a mis-tagged figure. Check the original filing before drawing conclusions.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 202331 Dec 202431 Dec 2025
DisclosureProfit onlyFull P&LFull P&LFull P&L
Profit & loss
Revenue (turnover)—£10.5m£10.5m£6m
Cost of sales—£262k£71.1k£0
Gross profit—£10.3m£10.4m£6m
Operating profit—£2.1m£5.2m£47.8m
Profit before tax—£2.1m£5.2m£47.8m
Profit after tax£2.9m£2m£5.2m£47.8m
Profit (best available)£2.9m£2m£5.2m£47.8m
Staff costs—£5.6m£4.6m£1.7m
Employees (average)63947328
Ratios
Profit margin—19.1%49.6%796.8%
Gross margin—97.5%99.3%100%
Revenue per employee—£112k£144k£214k
Profit per employee£46.4k£21.4k£71.4k£1.7m
Growth (year on year)
Revenue growth——▼0.3%▼43%
Profit growth—▼31.2%▲159.5%▲816.6%
Headcount growth—▲49.2%▼22.3%▼61.6%
Balance sheet — indirect signals, not revenue
Cash at bank£1.6m£2m£5.3m£0
Net assets£3.1m£5.1m£6.8m£48.1m
Fixed assets£188k£77.7k£26.3k£0
Current assets£4.1m£6m£8.8m£48.1m
Debtors£1.9m£2.1m£1.9m£0
Deferred income£344k£416k£396k£0
SourceFullAccounts · bulk data Aug 2024FullAccounts · bulk data Aug 2024FullAccounts · bulk data Aug 2025FullAccounts · bulk data Aug 2026
Derived from the latest filing

How the business works

Profit margin
796.8%
Profit ÷ revenue.
Gross margin
100%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£214k
Revenue ÷ average employees.
Profit per employee
£1.7m
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
0%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
0%
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
0%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▲608%
Now £48.1m
Cash at bank
▼100%
Now £0
Headcount
▼62%
Now 28
Deferred income
▼100%
Now £0
Fixed assets
▼100%
Now £0

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Iqvia Holdings Inc. (registered outside the UK register)ultimate parent75–100%
  2. Iqvia RDS UK Holdings Ltd.75–100%
  3. Iqvia RDS Holdings75–100%
  4. Iqvia Ltd.75–100%
  5. Pharmareview Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (28)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £47.8m), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.